- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
G
DNA
Ginkgo Bioworks Holdings Inc
15.12
-0.71-4.49%After Hours: 15.00 -0.12 -0.78%18:02 10/16 EDT
OPEN/PREV CLOSE16.25/15.83
TODAY RANGE14.99-16.50
VOL1.62M
MARKET CAP895.10M
52 WEEK RANGE5.00-17.58
AVG VOL (3M)1.74M
% TURNOVER2.74%
TURNOVER--
P/E (TTM)-2.5834
% RANGE9.54%
EPS(TTM)-5.8528
P/E(FORWARD)-2.8691
P/B1.367
BVPS11.06
DIVIDEND--
P/S3.621
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP837.65M
SHARES OUTSTANDING59.20M
NEXT EARNINGS--
FREE FLOAT55.40M
LOT SIZE1
EX-DATE08/20/2024
News
Press Releases
Financial Reports
Profile
Benzinga·10/08 14:39
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday
Simply Wall St·10/05 19:46
Do Lower Revenue Projections Reveal a Strategic Pivot for Ginkgo Bioworks (DNA)?
Simply Wall St·10/03 10:16
Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Shares Climb 45% But Its Business Is Yet to Catch Up
Simply Wall St·09/14 12:42
This Ginkgo Bioworks Holdings Insider Reduced Their Stake By 45%
TipRanks·09/11 02:10
Director’s Stock Sale: What It Means for Ginkgo Bioworks
Seeking Alpha·09/05 10:23
Ginkgo Bioworks enters into $100M equity sales deal
TipRanks·09/04 21:17
Ginkgo Bioworks Enters Sales Agreement for Stock Offering
Seeking Alpha·09/02 10:06
Ginkgo Bioworks: Structural Cost Issues Will Be Difficult To Resolve
TipRanks·08/29 20:29
Ginkgo Bioworks Settles Stockholder Derivative Actions
PR Newswire·08/29 20:05
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
Dow Jones·08/25 12:33
Ginkgo Bioworks Holdings Is Maintained at Sell by BTIG
Dow Jones·08/25 12:33
Ginkgo Bioworks Holdings Price Target Raised to $9.00/Share From $6.00 by BTIG
Same Industry
Name/Symbol
Change%
Price